Literature DB >> 11077493

The pylorus preserving Whipple procedure for the treatment of chronic pancreatitis.

L W Traverso1.   

Abstract

A schema is developed that outlines criteria to consider more than medical therapy for patients with severe pancreatitis that develop disabling abdominal pain. If the symptomatic patient has severe chronic pancreatitis that reaches the Cambridge Class V "marked" stage of image severity then endotherapy is indicated. If endotherapy fails then surgery is indicated. Usually these patients will have pathological changes centered in the pancreatic head and PPW is performed. After an average follow-up of > 4 years PPW was observed to provide either good to excellent relief of disabling abdominal pain. These patients were highly selected by the guidance of the anatomic profile of the composite pancreas. Long-term follow-up has never been available with cancer patients after the Whipple procedure. These chronic pancreatitis patients after PPW showed few GI side effects. In addition we did not observe a predisposition for diabetes other than that from the continued parenchymal destruction from smoldering chronic pancreatitis in the pancreatic remnant. Surgeons should avoid total pancreatectomy in patients, even if the patient is already diabetic. Marginal ulceration is highly associated with the total resection. From this personal experience using anatomic criteria and close follow-up, it is hoped that the long term outcomes of pain relief in virtually all patients after PPW will represent a benchmark for results after procedures which employ less resection. Therapy should be based on reliable imaging criteria to select patients. Then the outcomes of new and promising procedures such as lithotripsy or limited head resections can be compared to the benchmarks derived after PPW. None of the new procedures, however address the main problem after PPW of remnant pancreatitis in the pancreatic body/tail. Even though this discomfort is no longer disabling after head resection remnant pancreatitis does occur in approximately one out of four patients.

Entities:  

Mesh:

Year:  2000        PMID: 11077493     DOI: 10.1024/1023-9332.6.5.259

Source DB:  PubMed          Journal:  Swiss Surg        ISSN: 1023-9332


  6 in total

1.  Surgical treatment of chronic pancreatitis using Frey's procedure: a Brazilian 16-year single-centre experience.

Authors:  Martinho Antonio Gestic; Francisco Callejas-Neto; Elinton Adami Chaim; Murillo Pimentel Utrini; Everton Cazzo; Jose Carlos Pareja
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

2.  Total pancreatectomy with islet cell autotransplantation as the initial treatment for minimal-change chronic pancreatitis.

Authors:  Gregory C Wilson; Jeffrey M Sutton; Milton T Smith; Nathan Schmulewitz; Marzieh Salehi; Kyuran A Choe; John E Brunner; Daniel E Abbott; Jeffrey J Sussman; Syed A Ahmad
Journal:  HPB (Oxford)       Date:  2014-10-09       Impact factor: 3.647

Review 3.  Management of pain in small duct chronic pancreatitis.

Authors:  Shailesh V Shrikhande; Jörg Kleeff; Helmut Friess; Markus W Büchler
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors.

Authors:  Khe T C Tran; Hans G Smeenk; Casper H J van Eijck; Geert Kazemier; Wim C Hop; Jan Willem G Greve; Onno T Terpstra; Jan A Zijlstra; Piet Klinkert; Hans Jeekel
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

5.  Pylorus resection or pylorus preservation in partial pancreatico-duodenectomy (PROPP study): study protocol for a randomized controlled trial.

Authors:  Thilo Hackert; Thomas Bruckner; Colette Dörr-Harim; Markus K Diener; Phillip Knebel; Werner Hartwig; Oliver Strobel; Stefan Fritz; Lutz Schneider; Jens Werner; Markus W Büchler
Journal:  Trials       Date:  2013-02-14       Impact factor: 2.279

Review 6.  Advances in surgical treatment of chronic pancreatitis.

Authors:  Qingqiang Ni; Lin Yun; Manish Roy; Dong Shang
Journal:  World J Surg Oncol       Date:  2015-02-08       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.